phase readout
saveNCT05905926: Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C
ENROLLING_BY_INVITATIONupdated 2mo ago
community read0 votes
Sponsor: Ardelyx. Phase: PHASE3. Conditions: Irritable Bowel Syndrome With Constipation (IBS-C)
view source ↗
comments(0)
5-min edit window · permanent after that